24 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
COVID-19 pandemic, may adversely impact our business, financial condition, and results of operations, including our preclinical studies and clinical … altogether; increased adverse events and deaths in our clinical trials due to pandemic-related infections; increased rates of patients withdrawing from
ARS
zzmd7jyp15g
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
lwgdfvr kou3
11 Aug 22
Definitive proxy
4:04pm
S-3
1k30rz69
9 Aug 22
Shelf registration
12:00am
10-K
6783phvcdo6uts882yyi
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
ca7 of595wq5ja2
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
10-Q
3vkc l5q05
2 Sep 21
Quarterly report
4:28pm
424B4
opc1a1dorfkx8sgu uo
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
k5rggtnq
19 Jul 21
IPO registration (amended)
6:09am
CORRESP
yzdw ogvlygbu
12 Jul 21
Correspondence with SEC
12:00am
S-1
ue89ktp6xale9pa 4p
1 Jul 21
IPO registration
4:05pm